These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14643093)

  • 1. Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine.
    Semenova S; Markou A
    Biol Psychiatry; 2003 Dec; 54(11):1249-64. PubMed ID: 14643093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
    Semenova S; Markou A
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):731-46. PubMed ID: 20627663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
    Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
    Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
    Rylkova D; Boissoneault J; Isaac S; Prado M; Shah HP; Bruijnzeel AW
    Neuropeptides; 2008 Jun; 42(3):215-27. PubMed ID: 18468678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats.
    Liu J; Pan H; Gold MS; Derendorf H; Bruijnzeel AW
    Neuropharmacology; 2008 Oct; 55(5):812-8. PubMed ID: 18634811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
    Watkins SS; Stinus L; Koob GF; Markou A
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
    Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):280-92. PubMed ID: 12712232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats.
    Markou A; Harrison AA; Chevrette J; Hoyer D
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):133-42. PubMed ID: 15452682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
    Zhornitsky S; Potvin S; Stip E; Rompré PP
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models and treatments for addiction and depression co-morbidity.
    Paterson NE; Markou A
    Neurotox Res; 2007 Jan; 11(1):1-32. PubMed ID: 17449445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
    Harrison AA; Liem YT; Markou A
    Neuropsychopharmacology; 2001 Jul; 25(1):55-71. PubMed ID: 11377919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats.
    Semenova S; Jin X; McClure-Begley TD; Tadman MP; Marks MJ; Markou A
    Pharmacol Biochem Behav; 2018 Aug; 171():54-65. PubMed ID: 29908200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oxytocin on nicotine withdrawal in rats.
    Manbeck KE; Shelley D; Schmidt CE; Harris AC
    Pharmacol Biochem Behav; 2014 Jan; 116():84-9. PubMed ID: 24239789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.
    Der-Avakian A; Markou A
    Behav Pharmacol; 2010 Jul; 21(4):359-68. PubMed ID: 20571366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats.
    Paterson NE; Myers C; Markou A
    Psychopharmacology (Berl); 2000 Nov; 152(4):440-6. PubMed ID: 11140337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
    Bruijnzeel AW; Zislis G; Wilson C; Gold MS
    Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of calcium channel antagonists on nonsomatic signs of nicotine and D-amphetamine withdrawal in mice.
    Biała G; Polak P; Michalak A; Kruk-Słomka M; Budzyńska B
    Pharmacol Rep; 2014 Apr; 66(2):212-22. PubMed ID: 24911072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.